  See all
 |
Articles: Cardiac/Hypertension |
Prior Articles
Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease
Pharmacoepidemiology and Drug Safety, 09/04/09
The effect of selected patients characteristics on the choice of antihypertensive medication in the elderly in Slovakia
Pharmacoepidemiology and Drug Safety, 09/04/09 The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada
Pharmacoepidemiology and Drug Safety, 09/04/09 Beta-blockers for hypertension: Are they going out of style?
Cleveland Clinic Journal of Medicine, 09/03/09
Free full text
Clonidine in Perioperative Medicine and Intensive Care Unit: More Than An Anti-Hypertensive Drug
Current Drug Targets, 09/03/09 An algorithm to identify incident myocardial infarction using Medicaid data
Pharmacoepidemiology and Drug Safety, 09/03/09 Resistant disease or resistant patient: Problems with adherence to cardiovascular medications in the elderly
Geriatrics, 09/03/09
Free full text
Beta-blockers in the Perioperative Period: Are there Indications other than Prevention of Cardiac Ischemia
Current Drug Targets, 09/02/09 Increase in lipid-lowering treatment rates among TRICARE beneficiaries: a population-based study
Pharmacoepidemiology and Drug Safety, 09/02/09 Effects of thoracic epidural anaesthesia on cardiac repolarization
Clinical and Experimental Pharmacology and Physiology, 09/02/09 Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function
Current Drug Targets, 09/02/09 CRESTOR reduced risk of cardiovascular events in elderly patients in new analysis of JUPITER
AstraZeneca, 09/01/09
Free full text
Effect of beta-Blockers on Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery
Current Drug Targets, 09/01/09 Cytokinetics Presents Phase IIa Clinical Trials Data Relating to Omecamtiv Mecarbil at the European Society of Cardiology Congress 2009
Cytokinetics, 09/01/09
Free full text
Study Shows Otamixaban substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Sanofi-aventis, 08/31/09
Free full text
Phase III head to head trial showed ticagrelor reduced cardiovascular death and heart attacks over clopidogrel in acute coronary syndromes patients
AstraZeneca, 08/31/09
Free full text
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix in Acute Coronary Syndrome Patients Undergoing Angioplasty
Bristol Myers-Squibb Company, 08/31/09
Free full text
New REVERSE Analysis Reinforces Improvements Seen in Mild Heart Failure Patients with Cardiac Resynchronization Therapy
Medtronic, 08/31/09
Free full text
New large-scale, global study provides additional information about an intensified dose-regimen of plavix in acute coronary syndrome patients undergoing angioplasty
Sanofi-aventis, 08/31/09
Free full text
Reducing Perioperative Myocardial Infarction with Anesthetic Drugs and Techniques
Current Drug Targets, 08/28/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
